To investigate the potential biological impacts of distinct BRAF mutations on CRC cells, BRAF V600E (class I), G469V (class II), D594A (class III) mutant and WT MC38 stable cell lines were established by virus infection. This evidence concerns the gene BRAF and colorectal carcinoma.